Why Geron Corporation Shares Tumbled
An SEC filing lets the wind out of Geron's sails. Should investors buy the dip or stick to the sidelines?
3 Humongous Health-Care Stocks This Week
Why Ariad, Prana, and Geron enjoyed humongous gains this week.
3 High-Risk, High-Reward Biotech Stocks for Long Term Investors
Everyone wants to get rich, but investing in the wrong developmental companies can have disastrous consequences. Here are three companies with game-changing potential that have yet to hit their stride -- and may payoff in the long run.